Celgene (CELG) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Celgene Corp  (NASDAQ: CELG)


Celgene's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Celgene's ROA in the third quarter of 2019?
Celgene Corp achieved a return on average assets (ROA) of 15.23 % in its third quarter of 2019, this is above CELG's average return on assets of 6.41%.
Celgene Corps assets during the 12 months ending in the third quarter of 2019 are valued at $38 billion

ROA has improved compared to 14.31% in the second quarter of 2019, due to net income growth.

However, within the Healthcare sector 54 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2019 quarter, so far to 334, from total ROA ranking in the second quarter of 2019 at 378.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Total Assets Change 20.89 % 17.16 % 8.92 % 28.11 % 7.81 %
Y / Y Net Income Change 56.28 % 50.33 % 82.62 % - 9.51 %
Net Income (TTM) in million 5,880 5,271 4,745 4,046 2,892
Return On Assets (TTM) 15.23 % 14.31 % 13.4 % 11.68 % 8.86 %
CELG's Total Ranking # 334 # 378 # 437 # 633 # 811
Total Assets (TTM) in million 41,363 39,183 37,639 36,296 34,215
Seq. Total Assets Change 5.56 % 4.1 % 3.7 % 6.08 % 2.31 %
Seq. Net Income Change 7.64 % 1.68 % 43.99 % -0.83 % 3.54 %

CELG's 5 Years Annual ROA >> Back to CELG Management Effectiveness >> Compare CELG ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 29
Sector # 55
Overall # 321

Return On Assets Statistics
High Average Low
16.45 %
6.41 %
-41.93 %
(Dec. 31, 2009)   (March 31, 2008)





Financial Statements
Celgene's Assets $ 41,363 million CELG's Balance sheet
Celgene's Income $ 1,691 million Quarterly CELG's Income Statement
CELG's Income by Division See CELG's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (FY 2014)
FY (Dec. 31, 2014)
Y / Y Total Assets Change 17.71 % 7.32 % 3.82 % 56.02 % 9.53 %
Total Assets in million 35,480 30,141 28,086 27,053 17,340
Y / Y Net Income Change 37.62 % 47.06 % 24.79 % -19.9 % 37.93 %
Net Income in million 4,046 2,940 1,999 1,602 2,000
Annual Return On Assets 11.4 % 9.75 % 7.12 % 5.92 % 11.53 %

CELG's 5 Years Annual ROA >> Back to CELG Management Effectiveness >> Compare CELG ROA to its Competitors



Comment on CELG's ROA in the fiscal year ending 2018
In the fiscal year 2018 ROA improved to 11.4 % compared to prior year, due to annual net income growth of 37.62 % to $4,046.00 million, while value of Celgene's overall assets grew just by 17.71 % to $35,480.00 million, compared to $35,480.00 a year before.


More Return On Assets Ratios
CELG's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CELG's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CELG's Competitors
Subscribers only: Roa for Celgene's Suppliers
Subscribers only: Return On Assets for CELG's Customers

You may also want to know
CELG's Roi CELG's Inventory Turnover Ratio CELG's Growth Rates CELG's Dividend Comparisons
CELG's Profitability Ratios CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Roe CELG's Valuation Ratios CELG's Financial Strength Ratios CELG's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector ROA
Exelixis Inc   38.32 %
Ligand Pharmaceuticals Incorporated  36.43 %
Oramed Pharmaceuticals Inc  35.60 %
Vanda Pharmaceuticals Inc   31.81 %
Orgenesis Inc   31.38 %
Vertex Pharmaceuticals Inc  31.00 %
Strongbridge Biopharma plc  29.96 %
Nrc Health  29.69 %
Biocorrx Inc   28.44 %
Remedent Inc   28.29 %
Corcept Therapeutics Inc  26.15 %
Harrow Inc   26.14 %
Idexx Laboratories Inc  25.50 %
Siga Technologies Inc  24.34 %
Arrowhead Pharmaceuticals Inc   24.01 %
Biospecifics Technologies Corp  21.86 %
Mettler toledo International Inc   20.83 %
Abiomed Inc   20.73 %
Biogen Inc   20.45 %
Eli Lilly And Company  20.06 %
Alpha Pro Tech Ltd   19.81 %
Chemed Corporation  19.09 %
Waters Corporation  18.66 %
Align Technology inc   18.65 %
Regeneron Pharmaceuticals Inc   16.59 %
Fonar Corporation  16.05 %
Pro dex Inc   15.76 %
Masimo Corp  15.60 %
Intuitive Surgical Inc   15.53 %
Celgene Corp  15.31 %

Date modified: 2026-09-08T15:09:41+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.